CASI Pharmaceuticals Inc (CASI)
5.74
+0.19
(+3.42%)
USD |
NASDAQ |
Nov 14, 16:00
5.46
-0.28
(-4.88%)
After-Hours: 18:04
CASI Pharmaceuticals Total Assets (Quarterly): 51.27M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 51.27M |
| March 31, 2024 | 58.01M |
| December 31, 2023 | 75.27M |
| September 30, 2023 | 74.23M |
| June 30, 2023 | 77.87M |
| March 31, 2023 | 88.40M |
| December 31, 2022 | 96.23M |
| September 30, 2022 | 127.91M |
| June 30, 2022 | 118.86M |
| March 31, 2022 | 129.56M |
| December 31, 2021 | 138.30M |
| September 30, 2021 | 136.27M |
| June 30, 2021 | 144.53M |
| March 31, 2021 | 148.09M |
| December 31, 2020 | 127.73M |
| September 30, 2020 | 134.24M |
| June 30, 2020 | 91.57M |
| March 31, 2020 | 99.48M |
| December 31, 2019 | 102.63M |
| September 30, 2019 | 109.07M |
| June 30, 2019 | 117.09M |
| March 31, 2019 | 131.06M |
| December 31, 2018 | 113.41M |
| September 30, 2018 | 120.31M |
| June 30, 2018 | 87.71M |
| Date | Value |
|---|---|
| March 31, 2018 | 71.16M |
| December 31, 2017 | 45.10M |
| September 30, 2017 | 22.72M |
| June 30, 2017 | 24.13M |
| March 31, 2017 | 26.18M |
| December 31, 2016 | 27.71M |
| September 30, 2016 | 24.76M |
| June 30, 2016 | 18.97M |
| March 31, 2016 | 14.52M |
| December 31, 2015 | 5.826M |
| September 30, 2015 | 7.102M |
| June 30, 2015 | 8.578M |
| March 31, 2015 | 10.19M |
| December 31, 2014 | 11.31M |
| September 30, 2014 | 12.41M |
| June 30, 2014 | 13.48M |
| March 31, 2014 | 14.62M |
| December 31, 2013 | 15.51M |
| September 30, 2013 | 16.26M |
| June 30, 2013 | 17.54M |
| March 31, 2013 | 18.49M |
| December 31, 2012 | 8.978M |
| September 30, 2012 | 9.090M |
| June 30, 2012 | 10.23M |
| March 31, 2012 | 12.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
51.27M
Minimum
Jun 2024
148.09M
Maximum
Mar 2021
106.34M
Average
102.63M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 12.90B |
| Zai Lab Ltd | 987.37M |
| China SXT Pharmaceuticals Inc | 23.13M |
| Adagene Inc | 100.78M |
| LakeShore Biopharma Co Ltd | 220.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 42.25M |
| Shareholders Equity (Quarterly) | 9.021M |
| Debt to Equity Ratio | 2.047 |
| Current Ratio | 3.882 |
| Net Debt Paydown Yield | -4.65% |